英文名称 Obatoclax Mesylate (GX15-070) 生化机理 Obatoclax Mesylate(GX15-070)是一种 Bcl-2 拮抗剂,在无细胞实验中的Ki值为0.22 μM,可帮助克服 MCL-1 介导的细胞凋亡抵抗。第 3 阶段 储存温度 -80℃储存 运输条件 超低温冰袋运输 产品介绍 Information Obatoclax Mesylate (GX15-070) is an ...
商品名称 Obatoclax mesylate (GX15-070) 品牌 丰晖生物 货号 A10665 名称 Obatoclax mesylate (GX15-070) 简介 Bcl-2 homology domain-3 (BH3) mimetic,antagonize all antiapoptotic Bcl-2 family proteins (average IC50, 3 umol/L), including Mcl-1 (IC50, 2.9 umol/L) and Bfl-1 (IC50, ...
Obatoclax Mesylate (GX15-070)是一种Bcl-2拮抗剂,无细胞试验中Ki为0.22 μM,可以协助抑制MCL-1介导的抗细胞凋亡作用。 特性 Obatoclax是有应用前景的小分子Bcl-2拮抗剂,抑制Bcl-2蛋白家族所有相关的膜结构,包括 Mcl-1。 靶点 Bcl-2 (Cell-free assay) ...
Obatoclax Mesylate (GX15-070 Mesylate),又称奥巴克拉甲磺酸盐,是BH3模拟物,是Bcl-2拮抗剂,Ki值为0.22 μM,通过结合Bcl-2的BH3结合位点抑制Bcl-2活性,诱导BAX或BAK依赖性的细胞凋亡,具有抗癌活性。 产品性质 英文别名(English Synonym) Obatoclax Mesylate, GX15-070 Mesylate ...
Obatoclax Mesylate (GX15-070) Obatoclax Mesylate (GX15-070) 产品别名:2-[2-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-3-甲氧基-2H-吡咯-5-基]-1H-吲哚甲磺酸盐 CAS NO.:803712-79-0 分子式:C20H19N3O.CH4O3S 分子量:413.49002
点击次数:68发布时间:2016/12/15更新日期:2021/11/4 16:07:38 所在地:中国大陆 产品型号:1G/25G/100G/500G/1KG可按客户要求 简单介绍:现货优势产品,Obatoclax Mesylate (GX15-070)CAS:80407-64-3生产厂家 哪里有我司秉着产品质量,同时为您节省实验经费,产品价格与质检单请于销售索要,如果质量问题可退款...
GX15-070, Obatoclax SizePriceAvailabilityQuantity 2mgUSD 55USD55In stock 5mgUSD 80USD80In stock 10mgUSD 130USD130In stock 25mgUSD 250USD250In stock Free Delivery on orders overUSD 500Bulk Inquiry? Quality Control & Documentation Purity: >99.0% ...
上海陶术生物科技有限公司是专业生产Obatoclax Mesylate;奥巴克拉盐酸盐Obatoclax|||GX15-070;Obatoclax|||GX15-070|||奥巴克拉甲磺酸盐T6275生产厂家,提供Obatoclax Mesylate;奥巴克拉盐酸盐Obatoclax|||GX15-070;Obatoclax|||GX15-070|||奥巴克拉甲磺酸盐型号,Obatocl
Downregulation of Beclin-1, which is capable of crosstalk between apoptosis and autophagy, affects GX15-070-induced cell death through apoptosis but not autophagy. Taken together, GX15-070 treatment in ALL could be an alternative regimen to overcome glucocorticoid resistance by inducing BAK-dependent...
GX15-070 predominately induces a non-apoptotic form of cell death in rhabdomyosarcoma cells, as evident by lack of typical apoptotic features such as DNA fragmentation or caspase activation and by insensitivity to the broad-range caspase inhibitor zVAD.fmk. Instead, GX15-070 triggers massive ...